Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers

Personalized Medicine in Genitourinary Oncology Is Happening Now

“…After treatment, a lot of health care resources are utilized in performing surveillance imaging with the hope of detecting cancer recurrences early. However, as discussed by Ahmed et al [12], biomarkers can help in stratifying patients into different risk groups that can be monitored with different intensity. For testicular cancer, a disease for which the long-term impact of surveillance is arguably the most significant, Fankhauser et al [13] review novel circulating RNA-based biomarkers that have the potential to outperform imaging.…”